NEW YORK, Dec. 28, 2017 /PRNewswire/ -- Global Needle-free Injection Systems Market was valued at $8.20 billion in 2016, and is estimated to reach $24.9 billion by 2023, growing at a CAGR of 17.4% during the forecast period. Needle free injection technology (NFIT) includes a wide range of drug delivery systems which are used to drive drugs through the skin using any of the forces such as Lorentz, Shock waves, pressure by gas or electrophoresis. The process propels the drug to pass through the skin, and virtually nullifies the use of hypodermic needles. The technology is highly beneficial in the pharma industry and also it is widely popular in the developing countries, as it is used in mass immunization programmes, bypassing the chances of needle stick injuries and avoiding other complications including those arising due to multiple use of single needle.Read the full report: https://www.reportlinker.com/p05258054
Based on Product, the market is segmented into Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors. Based on Source of Power, the market is segmented into Spring-Based Needle-Free Injectors and Gas Propelled/ Air Forced Injector Systems. Based on Type, the market is segmented into Liquid-Based Needle Free Injectors, Projectile/Depot-Based Needle-Free Injectors, and Powder-Based Needle Free Injectors. Based on Site of Delivery, the market is segmented into Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors. Based on Usability, the market is segmented into Disposable Needle-Free Injectors and Reusable Needle-Free Injectors. Based on Application, the market is segmented into Vaccine Delivery, Insulin Delivery, Pain Management, and Other Application. The report also covers geographical segmentation of Needle-free Injection Systems market. The geographies included in the report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. For the better analysis, the geographies are segmented into countries.The market research report covers the analysis of key stake holders of the Global Needle-free Injection Systems Market. Key companies profiled in the report include Endo International PLC, Antares Pharma, Inc, Pharmajet, Medical International Technology, Inc. (MIT), Injex Pharma AG, National Medical Products, Inc., Valeritas, Inc., European Pharma Group BV, Wright Medical Group, Inc., and Bioject Medical Technologies Inc.Read the full report: https://www.reportlinker.com/p05258054
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected]
US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
View original content:http://www.prnewswire.com/news-releases/global-needle-free-injection-systems-market-is-estimated-to-reach-249-billion-by-2023-300575830.html
SOURCE Reportlinker
